The AntiCancer Laboratory of Precision Medicine

 

AntiCancer has integrated its Histoculture Drug Response Assay (HDRA) and Patient Derived Orthotopic Xenograft ( PDOX) and orthotopic MetaMouse  cancer models into the AntiCancer Laboratory of Precision Medicine ( ALPM). The ALPM is being automated with artificial intelligence (AI). The ALPM  provides the leading and most patient - like models of cancer for drug discovery, drug evaluation, and individualized, precision cancer treatment as described in approximately 600 of AntiCancer's publications.